NM_021619.3:c.2T>C
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PVS1_SupportingPM2
The NM_021619.3(PRDM12):c.2T>C(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000437 in 1,372,526 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021619.3 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRDM12 | ENST00000253008.3 | c.2T>C | p.Met1? | start_lost | Exon 1 of 5 | 1 | NM_021619.3 | ENSP00000253008.2 | ||
PRDM12 | ENST00000676323.1 | c.2T>C | p.Met1? | start_lost | Exon 1 of 6 | ENSP00000502471.1 |
Frequencies
GnomAD3 genomes AF: 0.0000205 AC: 3AN: 146634Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000501 AC: 1AN: 199754Hom.: 0 AF XY: 0.00000897 AC XY: 1AN XY: 111514
GnomAD4 exome AF: 0.00000245 AC: 3AN: 1225892Hom.: 0 Cov.: 34 AF XY: 0.00000330 AC XY: 2AN XY: 606978
GnomAD4 genome AF: 0.0000205 AC: 3AN: 146634Hom.: 0 Cov.: 32 AF XY: 0.0000140 AC XY: 1AN XY: 71454
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.2T>C (p.M1?) alteration is located in coding exon 1 of the PRDM12 gene and consists of a T to C substitution at nucleotide position 2. This alters the methionine residue at the initiation codon (ATG). Variations that modify the initiation codon (ATG) are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame; however, there is an in-frame methionine one amino acid from the initiation site, which may result in N-terminal truncation of unknown functional significance. Based on data from gnomAD, the C allele has an overall frequency of 0.001% (1/199754) total alleles studied. The highest observed frequency was 0.001% (1/86632) of European (non-Finnish) alleles. This amino acid position is well conserved in available vertebrate species. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at